{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:51:04Z","timestamp":1793832664086,"version":"4.6.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["058299\/Z\/99"],"award-info":[{"award-number":["058299\/Z\/99"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_00017\/2"],"award-info":[{"award-number":["MC_UU_00017\/2"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RE\/13\/1\/30181"],"award-info":[{"award-number":["RE\/13\/1\/30181"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Adiposity is a major cause of morbidity and mortality in part due to effects on blood lipids. Nuclear magnetic resonance (NMR) spectroscopy provides direct information on &gt;130 biomarkers mostly related to blood lipid particles.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Among 28,934 Mexican adults without chronic disease and not taking lipid-lowering therapy, we examine the cross-sectional relevance of body-mass index (BMI), waist circumference (WC), waist-hip ratio (WHR), and hip circumference (HC) to NMR-measured metabolic biomarkers. Confounder-adjusted associations between each adiposity measure and NMR biomarkers are estimated before and after mutual adjustment for other adiposity measures.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Markers of general (ie, BMI), abdominal (ie, WC and WHR) and gluteo-femoral (ie, HC) adiposity all display similar and strong associations across the NMR-platform of biomarkers, particularly for biomarkers that increase cardiometabolic risk. Higher adiposity associates with higher levels of Apolipoprotein-B (about 0.35, 0.30, 0.35, and 0.25\u2009SD higher Apolipoprotein-B per 2-SD higher BMI, WHR, WC, and HC, respectively), higher levels of very low-density lipoprotein particles (and the cholesterol, triglycerides, and phospholipids within these lipoproteins), higher levels of all fatty acids (particularly mono-unsaturated fatty acids) and multiple changes in other metabolic biomarkers including higher levels of branched-chain amino acids and the inflammation biomarker glycoprotein acetyls. Associations for general and abdominal adiposity are fairly independent of each other but, given general and abdominal adiposity, higher gluteo-femoral adiposity is associated with a strongly favourable cardiometabolic lipid profile.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our results provide insight to the lipidic and metabolomic signatures of different adiposity markers in a previously understudied population where adiposity is common but lipid-lowering therapy is not.<\/jats:p><\/jats:sec>","DOI":"10.1038\/s43856-022-00208-2","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T23:57:04Z","timestamp":1668470224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Adiposity and NMR-measured lipid and metabolic biomarkers among 30,000 Mexican adults"],"prefix":"10.1038","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2298-3768","authenticated-orcid":false,"given":"Diego","family":"Aguilar-Ramirez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Herrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9390-3871","authenticated-orcid":false,"given":"Jesus","family":"Alegre-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Staplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"Ram\u00edrez-Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0641-2220","authenticated-orcid":false,"given":"Louisa Friedrichs","family":"Gnatiuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8621-5488","authenticated-orcid":false,"given":"Frederik","family":"Romer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7655-5905","authenticated-orcid":false,"given":"Eirini","family":"Trichia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9181-6886","authenticated-orcid":false,"given":"Fiona","family":"Bragg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9826-6322","authenticated-orcid":false,"given":"Rachel","family":"Wade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Lewington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7792-9422","authenticated-orcid":false,"given":"Jonathan R.","family":"Emberson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Kuri-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Tapia-Conyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,14]]},"reference":[{"key":"208_CR1","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(17)32366-8","volume":"390","author":"E Gakidou","year":"2017","unstructured":"Gakidou, E. et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390, 1345\u20131422 (2017).","journal-title":"Lancet"},{"key":"208_CR2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1614362","volume":"377","author":"The GBD.","year":"2017","unstructured":"The GBD. 2015 Obesity Collaborators. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N. Engl. J. Med. 377, 13\u201327 (2017).","journal-title":"N. Engl. J. Med."},{"key":"208_CR3","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S0140-6736(09)60318-4","volume":"373","author":"Prospective Studies Collaboration.","year":"2009","unstructured":"Prospective Studies Collaboration. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 373, 1083\u20131096 (2009).","journal-title":"Lancet"},{"key":"208_CR4","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1161\/CIRCULATIONAHA.117.033278","volume":"138","author":"KH Wade","year":"2018","unstructured":"Wade, K. H. et al. Assessing the Causal Role of Body Mass Index on Cardiovascular Health in Young Adults: Mendelian Randomization and Recall-by-Genotype Analyses. Circulation 138, 2187\u20132201 (2018).","journal-title":"Circulation"},{"key":"208_CR5","doi-asserted-by":"publisher","first-page":"e1001765","DOI":"10.1371\/journal.pmed.1001765","volume":"11","author":"P W\u00fcrtz","year":"2014","unstructured":"W\u00fcrtz, P. et al. Metabolic signatures of adiposity in young adults: mendelian randomization analysis and effects of weight change. Sheehan NA, editor. PLoS Med. 11, e1001765 (2014).","journal-title":"PLoS Med"},{"key":"208_CR6","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1016\/j.jacc.2018.09.066","volume":"72","author":"JA Bell","year":"2018","unstructured":"Bell, J. A. et al. Associations of body mass and fat indexes with cardiometabolic traits. J. Am. Coll. Cardiol. 72, 3142\u20133154 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"208_CR7","doi-asserted-by":"crossref","unstructured":"Neeland, I. J. et al. Metabolomics profiling of visceral adipose tissue: results from MESA and the NEO study. JAHA https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.118.010810 (2019).","DOI":"10.1161\/JAHA.118.010810"},{"key":"208_CR8","doi-asserted-by":"publisher","first-page":"682","DOI":"10.21149\/11630","volume":"62","author":"S Barquera","year":"2020","unstructured":"Barquera, S. et al. Obesidad en M\u00e9xico, prevalencia y tendencias en adultos. Ensanut 2018-19. Salud Publica Mex 62, 682\u2013692 (2020).","journal-title":"Salud Publica Mex"},{"key":"208_CR9","doi-asserted-by":"publisher","first-page":"944","DOI":"10.2337\/dc20-2276","volume":"44","author":"D Aguilar-Ramirez","year":"2021","unstructured":"Aguilar-Ramirez, D. et al. Changes in the diagnosis and management of diabetes in mexico city between 1998\u20132004 and 2015\u20132019. Diabetes Care. 44, 944\u2013951 (2021).","journal-title":"Diabetes Care."},{"key":"208_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/ije\/dyl042","volume":"35","author":"R Tapia-Conyer","year":"2006","unstructured":"Tapia-Conyer, R. et al. Cohort profile: the Mexico City Prospective Study. Int. J. Epidemiol. 35, 243\u2013249 (2006).","journal-title":"Int. J. Epidemiol"},{"key":"208_CR11","doi-asserted-by":"publisher","first-page":"113695","DOI":"10.1016\/j.ab.2020.113695","volume":"597","author":"V Muzakova","year":"2020","unstructured":"Muzakova, V., Beekhof, P. K. & Jansen, E. H. J. M. Very long-term stability of lipid biomarkers in human serum. Anal. Biochem. 597, 113695 (2020).","journal-title":"Anal. Biochem."},{"key":"208_CR12","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1093\/clinchem\/48.9.1627","volume":"48","author":"LD Youngman","year":"2002","unstructured":"Youngman, L. D., Clark, S., Manley, S., Peto, R. & Collins, R. Reliable measurement of glycated hemoglobin in frozen blood samples: implications for epidemiologic studies. Clin. Chem. 48, 1627\u20131629 (2002).","journal-title":"Clin. Chem."},{"key":"208_CR13","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1161\/CIRCGENETICS.114.000216","volume":"8","author":"P Soininen","year":"2015","unstructured":"Soininen, P., Kangas, A. J., W\u00fcrtz, P., Suna, T. & Ala-Korpela, M. Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. Circ. Cardiovasc. Genet. 8, 192\u2013206 (2015).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"208_CR14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B Methodol. 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. Ser. B Methodol."},{"key":"208_CR15","unstructured":"R Core Team. R: A language and environment for statistical computing. (R Foundation for Statistical Computing, Vienna, 2021)."},{"key":"208_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-244","volume":"14","author":"H Zhang","year":"2013","unstructured":"Zhang, H., Meltzer, P. & Davis, S. RCircos: an R package for Circos 2D track plots. BMC Bioinforma. 14, 244 (2013).","journal-title":"BMC Bioinforma."},{"key":"208_CR17","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1007\/s00125-019-05001-w","volume":"62","author":"AV Ahola-Olli","year":"2019","unstructured":"Ahola-Olli, A. V. et al. Circulating metabolites and the risk of type 2 diabetes: a prospective study of 11,896 young adults from four Finnish cohorts. Diabetologia. 62, 2298\u20132309 (2019).","journal-title":"Diabetologia."},{"key":"208_CR18","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.2337\/dc19-2348","volume":"43","author":"JA Bell","year":"2020","unstructured":"Bell, J. A. et al. Early metabolic features of genetic liability to type 2 diabetes: cohort study with repeated metabolomics across early life. Diabetes Care 43, 1537\u20131545 (2020).","journal-title":"Diabetes Care"},{"key":"208_CR19","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nm.2307","volume":"17.","author":"TJ Wang","year":"2011","unstructured":"Wang, T. J. et al. Metabolite profiles and the risk of developing diabetes. Nat. Med. 17., 448\u2013453 (2011).","journal-title":"Nat. Med."},{"key":"208_CR20","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.114.013116","volume":"131","author":"P W\u00fcrtz","year":"2015","unstructured":"W\u00fcrtz, P. et al. Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. Circulation. 131, 774\u2013785 (2015).","journal-title":"Circulation."},{"key":"208_CR21","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.jacc.2017.12.006","volume":"71","author":"MV Holmes","year":"2018","unstructured":"Holmes, M. V. et al. Lipids, lipoproteins, and metabolites and risk of myocardial infarction and stroke. J. Am. Coll. Cardiol. 71, 620\u2013632 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"208_CR22","doi-asserted-by":"publisher","first-page":"s338","DOI":"10.1590\/S0036-36342007000900005","volume":"49","author":"S Barquera","year":"2007","unstructured":"Barquera, S. et al. Dyslipidemias and obesity in Mexico. Salud p\u00fablica M\u00e9x 49, s338\u2013s347 (2007).","journal-title":"Salud p\u00fablica M\u00e9x"},{"key":"208_CR23","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nature05488","volume":"444","author":"JP Despr\u00e9s","year":"2006","unstructured":"Despr\u00e9s, J. P. & Lemieux, I. Abdominal obesity and metabolic syndrome. Nature 444, 881\u2013887 (2006).","journal-title":"Nature"},{"key":"208_CR24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","volume":"5","author":"P Libby","year":"2019","unstructured":"Libby, P. et al. Atherosclerosis. Nat. Rev. Dis. Primers 5, 56 (2019).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"208_CR25","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119\u20131131 (2017).","journal-title":"N. Engl. J. Med."},{"key":"208_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1812792","volume":"380","author":"DL Bhatt","year":"2019","unstructured":"Bhatt, D. L. et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N. Engl. J. Med. 380, 11\u201322 (2019).","journal-title":"N. Engl. J. Med."},{"key":"208_CR27","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/eurheartj\/eht571","volume":"36","author":"MV Holmes","year":"2015","unstructured":"Holmes, M. V. et al. Mendelian randomization of blood lipids for coronary heart disease. Eur. Heart J. 36, 539\u2013550 (2015).","journal-title":"Eur. Heart J."},{"key":"208_CR28","doi-asserted-by":"publisher","first-page":"e1003062","DOI":"10.1371\/journal.pmed.1003062","volume":"17","author":"TG Richardson","year":"2020","unstructured":"Richardson, T. G. et al. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: a multivariable Mendelian randomisation analysis. Rader DJ, editor. PLoS Med. 17, e1003062 (2020).","journal-title":"PLoS Med"},{"key":"208_CR29","doi-asserted-by":"publisher","first-page":"833","DOI":"10.2337\/dc15-2251","volume":"39","author":"M Guasch-Ferr\u00e9","year":"2016","unstructured":"Guasch-Ferr\u00e9, M. et al. Metabolomics in prediabetes and diabetes: a systematic review and meta-analysis. Diabetes Care 39, 833\u2013846 (2016).","journal-title":"Diabetes Care"},{"key":"208_CR30","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.2337\/db17-0199","volume":"66","author":"J Liu","year":"2017","unstructured":"Liu, J. et al. A Mendelian Randomization study of metabolite profiles, fasting glucose, and type 2 diabetes. Diabetes. 66, 2915\u20132926 (2017).","journal-title":"Diabetes."},{"key":"208_CR31","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.2337\/dc17-1642","volume":"40","author":"Q Wang","year":"2017","unstructured":"Wang, Q., Holmes, M. V., Davey Smith, G. & Ala-Korpela, M. Genetic support for a causal role of insulin resistance on circulating branched-chain amino acids and inflammation. Diabetes Care 40, 1779\u20131786 (2017).","journal-title":"Diabetes Care"},{"key":"208_CR32","doi-asserted-by":"publisher","first-page":"e63033","DOI":"10.7554\/eLife.63033","volume":"10","author":"H Julkunen","year":"2021","unstructured":"Julkunen, H., Cicho\u0144ska, A., Slagboom, P. E. & W\u00fcrtz, P. Nightingale Health UK Biobank Initiative. Metabolic biomarker profiling for identification of susceptibility to severe pneumonia and COVID-19 in the general population. eLife. 10, e63033 (2021).","journal-title":"eLife."},{"key":"208_CR33","doi-asserted-by":"publisher","first-page":"397","DOI":"10.7326\/M18-3502","volume":"171","author":"L Gnatiuc","year":"2019","unstructured":"Gnatiuc, L. et al. General and abdominal adiposity and mortality in Mexico City: a prospective study of 150 000 adults. Ann. Intern. Med. 171, 397 (2019).","journal-title":"Ann. Intern. Med."},{"key":"208_CR34","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.atherosclerosis.2005.12.027","volume":"189","author":"D Canoy","year":"2006","unstructured":"Canoy, D. et al. Serum lipid concentration in relation to anthropometric indices of central and peripheral fat distribution in 20,021 British men and women: results from the EPIC-Norfolk population-based cohort study. Atherosclerosis 189, 420\u2013427 (2006).","journal-title":"Atherosclerosis"},{"key":"208_CR35","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1093\/eurjpc\/zwab038","volume":"29","author":"L Gnatiuc","year":"2022","unstructured":"Gnatiuc, L. et al. Abdominal and gluteo-femoral markers of adiposity and risk of vascular-metabolic mortality in a prospective study of 150 000 Mexican adults. Eur. J. Prev. Cardiol. 29, 730\u2013738 (2022).","journal-title":"Eur. J. Prev. Cardiol"},{"key":"208_CR36","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrendo.2014.185","volume":"11","author":"F Karpe","year":"2015","unstructured":"Karpe, F. & Pinnick, K. E. Biology of upper-body and lower-body adipose tissue\u2014link to whole-body phenotypes. Nat. Rev. Endocrinol. 11, 90\u2013100 (2015).","journal-title":"Nat. Rev. Endocrinol."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-022-00208-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-022-00208-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-022-00208-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T05:07:39Z","timestamp":1728364059000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-022-00208-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,14]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["208"],"URL":"https:\/\/doi.org\/10.1038\/s43856-022-00208-2","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,14]]},"assertion":[{"value":"3 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"143"}}